‫این ایف ٹی کے تجربے کی ازسرنو تشکیل– آرٹیمِس نے موبائل پر مبنی دنیا کا پہلا ڈی سینٹرلائزڈ این ایف ٹی سوشل اینڈ ٹریڈنگ پلیٹ فارم لانچ کردیا

ہانگ کانگ،13جنوری 2022 /پی آر نیوز وائر/ – ہمیں آرٹیمِس  (Artemis)کے آغاز کا اعلان کرتے ہوئے فخر ہے، موبائل پر مبنی دنیا کا پہلا  ڈی  سینٹرلائزڈ این ایف ٹی  سماجی اور تجارتی پلیٹ فارم سولانا سے شروع ہو رہا ہے۔ فروری کے اختتام تک 0 فیصد ٹرانزیکشن فیس ٹریڈنگ کی پیشکش کرتے ہوئے، آرٹیمِس   اسے […]

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Bright Health Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – BHG

NEW YORK, Jan. 12, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Bright Health Group, Inc. (NYSE: BHG): (i) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued […]

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Meta Materials Inc. f/k/a Torchlight Energy Resources, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline– MMAT, MMTLP, TRCH

NEW YORK, Jan. 12, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Meta Materials Inc. f/k/a Torchlight Energy Resources, Inc. (NASDAQ: MMAT, TRCH) (OTC: MMTLP) between September 21, 2020 and December 14, 2021, both dates inclusive (the “Class Period”), of the important March […]

Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants and Outlines Initiatives to Address Omicron

Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron Multiple Efforts Underway to Address Omicron and Potential Future SARS-CoV-2 Variants WALTHAM, Mass., Jan. 12, 2022 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development […]